241 related articles for article (PubMed ID: 3957488)
41. The interaction between i.v. theophylline and chronic oral dosing with slow release nifedipine in volunteers.
Jackson SH; Shah K; Debbas NM; Johnston A; Peverel-Cooper CA; Turner P
Br J Clin Pharmacol; 1986 Apr; 21(4):389-92. PubMed ID: 3707813
[TBL] [Abstract][Full Text] [Related]
42. Effects of amiodarone on the pharmacokinetics and toxicity of digoxin in laboratory animals.
Staneva-Stoytcheva D; Kristeva E
Methods Find Exp Clin Pharmacol; 1992 Apr; 14(3):193-7. PubMed ID: 1625503
[TBL] [Abstract][Full Text] [Related]
43. Dose-dependence of the nifedipine/digoxin interaction?
Hutt HJ; Kirch W; Dylewicz P; Ohnhaus EE
Arch Toxicol Suppl; 1986; 9():209-12. PubMed ID: 3468899
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetics of single dose oral digoxin in patients with uncomplicated type II diabetes mellitus.
Gitanjali B; Adithan C; Raveendran R; Shashindran CH; Chandrasekar S
Int J Clin Pharmacol Ther Toxicol; 1992 Apr; 30(4):113-6. PubMed ID: 1572755
[TBL] [Abstract][Full Text] [Related]
45. Assessment of the potential pharmacokinetic interaction between digoxin and ethmozine.
MacFarland RT; Moeller VR; Pieniaszek HJ; Whitney CC; Marcus FI
J Clin Pharmacol; 1985 Mar; 25(2):138-43. PubMed ID: 3886709
[TBL] [Abstract][Full Text] [Related]
46. [Interaction between digoxin and nifedipine in the pharmacokinetic phase].
Jankowski A; Karwowski J; Marzec A; Nartowicz E
Kardiol Pol; 1987; 30 Suppl():72-5. PubMed ID: 3331401
[No Abstract] [Full Text] [Related]
47. [Chronopharmacokinetics of digoxin in compensated cardiac patients].
Kopecká J; Janků I; Pidrman V; Martínková J
Vnitr Lek; 1992 Jun; 38(6):566-72. PubMed ID: 1529562
[TBL] [Abstract][Full Text] [Related]
48. The bioavailability and pharmacokinetics of slow release nifedipine during chronic dosing in volunteers.
Debbas NM; Jackson SH; Shah K; Abrams SM; Johnston A; Turner P
Br J Clin Pharmacol; 1986 Apr; 21(4):385-8. PubMed ID: 3707812
[TBL] [Abstract][Full Text] [Related]
49. Effect of aspirin, furosemide, and commercial low-salt diet on digoxin pharmacokinetic properties in clinically normal cats.
Atkins CE; Snyder PS; Keene BW
J Am Vet Med Assoc; 1988 Nov; 193(10):1264-8. PubMed ID: 3204049
[TBL] [Abstract][Full Text] [Related]
50. Dose-independent pharmacokinetics of digoxin in humans.
Ochs HR; Greenblatt DJ; Bodem G; Harmatz JS
Am Heart J; 1978 Oct; 96(4):507-11. PubMed ID: 358815
[TBL] [Abstract][Full Text] [Related]
51. Bioavailability of digoxin: some pitfalls and problems.
Keller F; Rietbrock N
Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):549-56. PubMed ID: 23358
[TBL] [Abstract][Full Text] [Related]
52. Influence of soft gelatin on digoxin absorption.
O'Grady J; Johnson BF; Bye C; Sabey GA
Br J Clin Pharmacol; 1978 May; 5(5):461-3. PubMed ID: 656286
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of digoxin absorption by neomycin.
Lindenbaum J; Maulitz RM; Butler VP
Gastroenterology; 1976 Sep; 71(3):399-404. PubMed ID: 950089
[TBL] [Abstract][Full Text] [Related]
54. Digoxin and nifedipine.
Schwartz JB
Am J Cardiol; 1985 May; 55(12):31E-34E. PubMed ID: 3890507
[TBL] [Abstract][Full Text] [Related]
55. Characterization of the pharmacokinetic interaction between nifedipine and ethanol in the rat.
Boje KM; Fung HL
J Pharmacol Exp Ther; 1989 May; 249(2):567-71. PubMed ID: 2724140
[TBL] [Abstract][Full Text] [Related]
56. Effects of amiodarone on oral and intravenous digoxin kinetics in healthy subjects.
Santostasi G; Fantin M; Maragno I; Gaion RM; Basadonna O; Dalla-Volta S
J Cardiovasc Pharmacol; 1987 Apr; 9(4):385-90. PubMed ID: 2438499
[TBL] [Abstract][Full Text] [Related]
57. Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.
Echizen H; Eichelbaum M
Clin Pharmacokinet; 1986; 11(6):425-49. PubMed ID: 3542336
[TBL] [Abstract][Full Text] [Related]
58. [Pharmacokinetic studies on fluoro-alpha-acetyl-digoxin (author's transl)].
Bodem G; Wirth K; Zimmer A
Arzneimittelforschung; 1978; 28(2):322-5. PubMed ID: 580403
[TBL] [Abstract][Full Text] [Related]
59. Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationship.
Kleinbloesem CH; van Brummelen P; van Harten J; Danhof M; Breimer DD
Clin Pharmacol Ther; 1985 May; 37(5):563-74. PubMed ID: 3987180
[TBL] [Abstract][Full Text] [Related]
60. Effects of compensated heart failure on digoxin pharmacokinetics in cats.
Atkins CE; Snyder PS; Keene BW; Rush JE
J Am Vet Med Assoc; 1989 Oct; 195(7):945-50. PubMed ID: 2793576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
